Craig Chepke, MD, DFAPA explains the role of glutamate receptors in neurotransmission and depression treatment.
Supported by an educational grant from Axsome Therapeutics, Inc.
Craig Chepke, MD, DFAPA explains the role of glutamate receptors in neurotransmission and depression treatment.
Kristian Dambrino, DNP, PMHNP-BC explores how an old drug found new life in depression management.
Kristian Dambrino, DNP, PMHNP-BC explores why it takes weeks for traditional antidepressants to work, and what can be done in the meantime.
Craig Chepke, MD, DFAPA discusses how chronic stress alters glutamatergic signaling and contributes to MDD.
Kristian Dambrino, DNP, PMHNP-BC breaks down the pharmacology of this combination therapy.
Rakesh Jain, MD, MPH discusses common adverse effects and their impact on treatment discontinuation
Rakesh Jain, MD, MPH explores its unique mechanism and rapid effects on mood.
Rakesh Jain, MD, MPH discusses how astrocytes regulate glutamate and their impact on mood disorders.